Mitochondrial-derived peptides (Humanin, MOTS-c, and SHLP2) protect pancreatic islet cells and delay the onset and progression of type 2 diabetes mellitus in mice | Synapse
March 3, 2026
Mitochondrial-derived peptides (Humanin, MOTS-c, and SHLP2) protect pancreatic islet cells and delay the onset and progression of type 2 diabetes mellitus in mice
Key Points
Mitochondrial-derived peptides show protective effects on pancreatic islet cells, delaying type 2 diabetes onset.
The specific peptides, Humanin, MOTS-c, and SHLP2, were effective in a mouse model, preventing metabolic disturbances.
The study utilized a mouse model to examine how these peptides influence diabetes progression.
Findings support the potential of mitochondrial-derived peptides as therapeutic agents for type 2 diabetes management.